Quick Answer
Tango Therapeutics, Inc. reported Shares Outstanding of 135.94 million shares for fiscal year 2025.
Tango Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 135.94M | +26.2% |
| 2024 | 107.73M | +5.4% |
| 2023 | 102.20M | +15.9% |
| 2022 | 88.18M | +0.7% |
| 2021 | 87.60M | +0.1% |
| 2021 | 87.47M | +116.7% |
| 2020 | 40.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 111.57M | +3.9% | +0.6% |
| June 30, 2025 | 110.87M | +3.6% | +2.6% |
| March 31, 2025 | 108.11M | +1.3% | +0.4% |
| December 31, 2024 | 107.73M | +5.4% | +0.3% |
| September 30, 2024 | 107.41M | +5.5% | +0.3% |
| June 30, 2024 | 107.04M | +21.0% | +0.3% |
| March 31, 2024 | 106.73M | +21.0% | +4.4% |
| December 31, 2023 | 102.20M | +15.9% | +0.3% |
- Tango Therapeutics, Inc. showed an increase of +26.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Tango Therapeutics, Inc.’s shares outstanding has grown by 236.7% (from 40.37 million shares to 135.94 million shares).
- The most recent figure is from Tango Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: